You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
PerkinElmer CEO Robert Friel was named chairman, as the firm also announced a new CFO. Integrated Genomics appointed members to its SAB, and John Rossi won a prize from PNAS.
News in brief
Deborah Nickerson has been in the trenches of genomics almost since the beginning, but that wasn't always the plan. Today, she uses her experience in learning a new field to mentor her students.
The Ottawa Institute of Systems Biology is still getting its momentum going, but it's already seen promising work in proteomics and spawned collaborations among its members.
The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.
Included are a large-scale study of the human kinome, and a description of a database combining ETD spectra and protein sequence databases for peptide identification.
A separate deal under which Prometheus agreed to acquire 2 million shares of Rosetta at $4 per share has also been completed.
The system, which serves California's largest public healthcare district, is offering 23andMe's service at several outpatient centers in an effort to advance preventative care.
The university's new labs will conduct an array of 'omics studies of cancer, addiction, infection, and others.
Matrix Genomics' DNA home testing kits for Alzheimer's disease, breast cancer, and heart attack risk
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.